Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/EBIT

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 5.359.7111.3063.7525.37

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 5.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20255.35
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2025 5.35
-44.90
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,717.5 Cr -2.7% -3.7% -42.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,218.0 Cr -0.7% 3% -13.4% Stock Analytics
DIVIS LABORATORIES ₹175,158.0 Cr 1.9% 8.3% 5.8% Stock Analytics
CIPLA ₹126,710.0 Cr 0.5% 0.7% -2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,586.0 Cr -0.1% NA 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,496.0 Cr -2% -5.4% -7.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.7%

-3.7%

-42.2%

SENSEX

1.6%

2.1%

2.6%


You may also like the below Video Courses